Tel Aviv, Tel Aviv District, Israel The main department of described VC is located in the Herzliya. The company was established in Asia in Israel.
Among the most popular fund investment industries, there are Health Care, Pharmaceutical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Oncorus, ARTSaVIT, Pi Therapeutics.
The usual cause for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are Pontifax, M Ventures, MPM Capital. In the next rounds fund is usually obtained by UTC Investment Co., UBS Oncology Impact Fund, Surveyor Capital.
The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
Reunion Neuroscience | $103M | 02 May 2024 | Toronto, Ontario, Canada | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Photys Therapeutics | $75M | 08 Sep 2022 | Cambridge, Massachusetts, United States | ||
Bluejay Therapeutics | $41M | 16 Aug 2022 | - | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
Auron Therapeutics | $12M | 28 Jan 2021 | Massachusetts, United States | ||
BioSight | $27M | 02 Dec 2020 | North District | ||
Redpin Therapeutics | $15M | 25 Mar 2020 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
Reunion Neuroscience | $103M | 02 May 2024 | Toronto, Ontario, Canada | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Photys Therapeutics | $75M | 08 Sep 2022 | Cambridge, Massachusetts, United States | ||
Bluejay Therapeutics | $41M | 16 Aug 2022 | - | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
Auron Therapeutics | $12M | 28 Jan 2021 | Massachusetts, United States | ||
BioSight | $27M | 02 Dec 2020 | North District | ||
Redpin Therapeutics | $15M | 25 Mar 2020 | New York, United States |
